European Society of Hypertension Guidelines 2023: Latest Advances in Diagnostic and Therapeutic Approaches to Hypertension

Abstract

The publication of Hypertension, the Society's official publication, published the 2023 European Society of Hypertension (ESH) recommendations for the diagnosis and treatment of hypertension, which were announced during the 32nd European congress on the condition in Milan in 2023[1]. Based on the findings of research and meta-analyses published over the last five years, they provide a lot of additional details on several diagnostic and treatment elements of the illness in comparison to the previous recommendations released in 2018[2]. Debatable topics covered in the document include the involvement of renal denervation in hard-to-treat hypertension, the role of beta-blocking drugs in the therapeutic approach to high blood pressure, and target blood pressure values to be reached by antihypertensive medication. This editorial will highlight the key innovations in the document, which bases its recommendations on three levels of evidence: data from small clinical studies (evidence C), non-randomized clinical trials (evidence B), and randomized clinical trialormeta-analyses (evidence A) [1].